Stockholm3 - A new option to detect Prostate Cancer

Prostate cancer is the second most often diagnosed cancer and the sixth most prevalent cause of cancer mortality in males globally.1 It is usually screened by measuring prostate specific antigen (PSA) levels in the blood. However, the PSA test results in unnecessary biopsies, over-diagnosis, over-t...

Full description

Bibliographic Details
Main Authors: Moosa Zulfiqar Ali, Roshaan Ahmad, Amna Akmal
Format: Article
Language:English
Published: Pakistan Medical Association 2022-04-01
Series:Journal of the Pakistan Medical Association
Online Access:https://www.ojs.jpma.org.pk/index.php/public_html/article/view/5109
_version_ 1797820886150021120
author Moosa Zulfiqar Ali
Roshaan Ahmad
Amna Akmal
author_facet Moosa Zulfiqar Ali
Roshaan Ahmad
Amna Akmal
author_sort Moosa Zulfiqar Ali
collection DOAJ
description Prostate cancer is the second most often diagnosed cancer and the sixth most prevalent cause of cancer mortality in males globally.1 It is usually screened by measuring prostate specific antigen (PSA) levels in the blood. However, the PSA test results in unnecessary biopsies, over-diagnosis, over-treatment, and higher expenses.2 The Karolinska Institutet in Stockholm, Sweden, developed the Stockholm3 test to overcome PSA test’s shortcomings. ---Continue
first_indexed 2024-03-13T09:44:50Z
format Article
id doaj.art-c523b63953ea4bc3811f081ede78f8df
institution Directory Open Access Journal
issn 0030-9982
language English
last_indexed 2024-03-13T09:44:50Z
publishDate 2022-04-01
publisher Pakistan Medical Association
record_format Article
series Journal of the Pakistan Medical Association
spelling doaj.art-c523b63953ea4bc3811f081ede78f8df2023-05-25T04:22:17ZengPakistan Medical AssociationJournal of the Pakistan Medical Association0030-99822022-04-0172410.47391/JPMA.5109Stockholm3 - A new option to detect Prostate CancerMoosa Zulfiqar Ali0Roshaan Ahmad1Amna Akmal2Medical College, Combined Military Hospital, Lahore, PakistanMedical College, Combined Military Hospital, Lahore, Pakistan Medical College, Combined Military Hospital, Lahore, Pakistan Prostate cancer is the second most often diagnosed cancer and the sixth most prevalent cause of cancer mortality in males globally.1 It is usually screened by measuring prostate specific antigen (PSA) levels in the blood. However, the PSA test results in unnecessary biopsies, over-diagnosis, over-treatment, and higher expenses.2 The Karolinska Institutet in Stockholm, Sweden, developed the Stockholm3 test to overcome PSA test’s shortcomings. ---Continue https://www.ojs.jpma.org.pk/index.php/public_html/article/view/5109
spellingShingle Moosa Zulfiqar Ali
Roshaan Ahmad
Amna Akmal
Stockholm3 - A new option to detect Prostate Cancer
Journal of the Pakistan Medical Association
title Stockholm3 - A new option to detect Prostate Cancer
title_full Stockholm3 - A new option to detect Prostate Cancer
title_fullStr Stockholm3 - A new option to detect Prostate Cancer
title_full_unstemmed Stockholm3 - A new option to detect Prostate Cancer
title_short Stockholm3 - A new option to detect Prostate Cancer
title_sort stockholm3 a new option to detect prostate cancer
url https://www.ojs.jpma.org.pk/index.php/public_html/article/view/5109
work_keys_str_mv AT moosazulfiqarali stockholm3anewoptiontodetectprostatecancer
AT roshaanahmad stockholm3anewoptiontodetectprostatecancer
AT amnaakmal stockholm3anewoptiontodetectprostatecancer